Evidence map›Paper›PMID 26091285›Full record

ArticleJournal of natural products2015

Cytotoxic Indolocarbazoles from Actinomadura melliaura ATCC 39691.

Khaled A Shaaban, Sherif I Elshahawi, Xiachang Wang, Jamie Horn, Madan K Kharel, Markos Leggas, Jon S Thorson

Abstract read
In one paragraph

Article in Journal of natural products, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Naturally Occurring Organohalogen Compounds-A Comprehensive Review.Progress in the chemistry of organic natural products · 2023
    Review
  9. Article
  10. Diverse polyketides from the marine endophyticBiotechnology reports (Amsterdam, Netherlands) · 2022
    Article
  11. Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  12. Article
  13. Article
  14. RF-3192C and other polyketides from the marine endophyticMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2021
    Article
  15. Article
  16. Article
  17. OleD Loki as a Catalyst for Hydroxamate Glycosylation.Chembiochem : a European journal of chemical biology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Khaled A Shaaban
Sherif I Elshahawi
Xiachang Wang
Jamie Horn
Madan K Kharel§School of Pharmacy, University of Maryland Eastern Shore, Princess Anne, Maryland 21853, United States.
Markos Leggas
Jon S Thorson

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1TR000117
6 · The paper itself

Abstract

Actinomadura melliaura ATCC 39691, a strain isolated from a soil sample collected in Bristol Cove, California, is a known producer of the disaccharide-substituted AT2433 indolocarbazoles (6-9). Reinvestigation of this strain using new media conditions led to >40-fold improvement in the production of previously reported AT2433 metabolites and the isolation and structure elucidation of the four new analogues, AT2433-A3, A4, A5, and B3 (1-4). The availability of this broader set of compounds enabled a subsequent small antibacterial/fungal/cancer SAR study that revealed disaccharyl substitution, N-6 methylation, and C-11 chlorination as key modulators of bioactivity. The slightly improved anticancer potency of the newly reported N-6-desmethyl 1 (compared to 6) contrasts extensive SAR of monoglycosylated rebeccamycin-type topoisomerase I inhibitors where N-6 alkylation has contributed to improved potency and ADME. Complete 2D NMR assignments for the known metabolite BMY-41219 (5) and (13)C NMR spectroscopic data for the known analogue AT2433-B1 (7) are also provided for the first time.

Indexed as

ActinomycetalesAntibiotics, AntineoplasticCaliforniaCarbazolesHumansIndole AlkaloidsMicrobial Sensitivity TestsMicrococcus luteusMolecular StructureMycobacterium smegmatisNuclear Magnetic Resonance, BiomolecularSaccharomyces cerevisiaeSoil MicrobiologyStaphylococcus aureusTopoisomerase I InhibitorsAntibiotics, AntineoplasticAT 2433-B1CarbazolesIndole AlkaloidsrebeccamycinTopoisomerase I Inhibitors

Identifiers

PMID26091285
PMCPMC4515175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.